BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 28371454)

  • 1. Tumor biology remains the main determinant of prognosis in retroperitoneal sarcomas: a 14-year single-center experience.
    Ng DWJ; Tan GHC; Chia CS; Chee SK; Quek R; Farid M; Teo MCC
    Asia Pac J Clin Oncol; 2017 Oct; 13(5):e458-e465. PubMed ID: 28371454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes in treatment of retroperitoneal sarcomas: A 15 year single-institution evaluation of prognostic features.
    Abdelfatah E; Guzzetta AA; Nagarajan N; Wolfgang CL; Pawlik TM; Choti MA; Schulick R; Montgomery EA; Meyer C; Thornton K; Herman J; Terezakis S; Frassica D; Ahuja N
    J Surg Oncol; 2016 Jul; 114(1):56-64. PubMed ID: 27076350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncology outcomes in Retroperitoneal sarcomas: Prognostic factors in a Retrospective Cohort study.
    Garcia-Ortega DY; Villa-Zepeda O; Martinez-Said H; Cuellar-Hübbe M; Luna-Ortiz K
    Int J Surg; 2016 Aug; 32():45-9. PubMed ID: 27268726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with surgical treatment of retroperitoneal soft tissue sarcomas at a university hospital in Thailand.
    Sriussadaporn S; Sriussadaporn S; Pak-art R; Kritayakirana K; Prichayudh S; Samorn P
    J Med Assoc Thai; 2014 Jun; 97(6):598-614. PubMed ID: 25137877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-relapse outcomes after primary extended resection of retroperitoneal sarcoma: A report from the Trans-Atlantic RPS Working Group.
    MacNeill AJ; Miceli R; Strauss DC; Bonvalot S; Hohenberger P; Van Coevorden F; Rutkowski P; Callegaro D; Hayes AJ; Honoré C; Fairweather M; Cannell A; Jakob J; Haas RL; Szacht M; Fiore M; Casali PG; Pollock RE; Raut CP; Gronchi A; Swallow CJ
    Cancer; 2017 Jun; 123(11):1971-1978. PubMed ID: 28152173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence and survival analysis of resected soft tissue sarcomas of pelvic retroperitoneal structures.
    Doepker MP; Hanna KH; Thompson ZJ; Binitie OT; Letson DG; Gonzalez RJ
    J Surg Oncol; 2016 Jan; 113(1):103-7. PubMed ID: 26744131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent retroperitoneal sarcomas: Clinical outcomes of surgical treatment and prognostic factors.
    Tropea S; Mocellin S; Damiani GB; Stramare R; Aliberti C; Del Fiore P; Rossi CR; Rastrelli M
    Eur J Surg Oncol; 2021 May; 47(5):1201-1206. PubMed ID: 32950313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A contemporary large single-institution evaluation of resected retroperitoneal sarcoma.
    Bremjit PJ; Jones RL; Chai X; Kane G; Rodler ET; Loggers ET; Pollack SM; Pillarisetty VG; Mann GN
    Ann Surg Oncol; 2014 Jul; 21(7):2150-8. PubMed ID: 24615180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensity modulated radiation therapy and surgery for Management of Retroperitoneal Sarcomas: a single-institution experience.
    Cosper PF; Olsen J; DeWees T; Van Tine BA; Hawkins W; Michalski J; Zoberi I
    Radiat Oncol; 2017 Dec; 12(1):198. PubMed ID: 29216884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWG.
    Raut CP; Callegaro D; Miceli R; Barretta F; Rutkowski P; Blay JY; Lahat G; Strauss DC; Gonzalez R; Ahuja N; Grignani G; Quagliuolo V; Stoeckle E; De Paoli A; Pillarisetty VG; Nessim C; Swallow CJ; Bagaria S; Canter R; Mullen J; Gelderblom HJ; Pennacchioli E; van Coevorden F; Cardona K; Fiore M; Fairweather M; Gronchi A
    Clin Cancer Res; 2019 Apr; 25(8):2664-2671. PubMed ID: 30723141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant radiotherapy in retroperitoneal sarcomas. A Scandinavian Sarcoma Group study of 97 patients.
    Trovik LH; Ovrebo K; Almquist M; Haugland HK; Rissler P; Eide J; Engellau J; Monge OR; Nyhus AB; Elde IK; Jebsen NL
    Acta Oncol; 2014 Sep; 53(9):1165-72. PubMed ID: 25000415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Operative management of primary retroperitoneal sarcomas: a reappraisal of an institutional experience.
    Hassan I; Park SZ; Donohue JH; Nagorney DM; Kay PA; Nasciemento AG; Schleck CD; Ilstrup DM
    Ann Surg; 2004 Feb; 239(2):244-50. PubMed ID: 14745333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors of retroperitoneal soft tissue sarcomas: analysis of 132 cases.
    Chen CQ; Yin L; Peng CH; Cai Y; Li YF; Zhao R; Zhou HJ; Li HW
    Chin Med J (Engl); 2007 Jun; 120(12):1047-50. PubMed ID: 17637220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of histology on survival in retroperitoneal sarcomas.
    Brown RE; St Hill CR; Greene QJ; Farmer RW; Reuter NP; Callendar GG; Martin RC; McMasters KM; Scoggins CR
    Am J Surg; 2011 Dec; 202(6):748-52; discussion 752-3. PubMed ID: 22030405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors for reoperation of recurrent retroperitoneal sarcoma: The role of clinicopathological factors other than histologic grade.
    Yang JY; Kong SH; Ahn HS; Lee HJ; Jeong SY; Ha J; Yang HK; Park KJ; Lee KU; Choe KJ
    J Surg Oncol; 2015 Feb; 111(2):165-72. PubMed ID: 25244418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma.
    Keung EZ; Chiang YJ; Cormier JN; Torres KE; Hunt KK; Feig BW; Roland CL
    Cancer; 2018 Dec; 124(23):4495-4503. PubMed ID: 30317543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas.
    Squires MH; Ethun CG; Suarez-Kelly LP; Yu PY; Hughes TM; Shelby RD; Tran TB; Poultsides G; Charlson J; Gamblin TC; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick BA; Fields RC; Pollock RE; Grignol V; Cardona K; Howard JH
    J Surg Res; 2020 Jan; 245():577-586. PubMed ID: 31494391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in primary retroperitoneal soft-tissue sarcomas.
    Bevilacqua RG; Rogatko A; Hajdu SI; Brennan MF
    Arch Surg; 1991 Mar; 126(3):328-34. PubMed ID: 1998475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group.
    Toulmonde M; Bonvalot S; Méeus P; Stoeckle E; Riou O; Isambert N; Bompas E; Jafari M; Delcambre-Lair C; Saada E; Le Cesne A; Le Péchoux C; Blay JY; Piperno-Neumann S; Chevreau C; Bay JO; Brouste V; Terrier P; Ranchère-Vince D; Neuville A; Italiano A;
    Ann Oncol; 2014 Mar; 25(3):735-742. PubMed ID: 24567518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets.
    Gronchi A; Miceli R; Shurell E; Eilber FC; Eilber FR; Anaya DA; Kattan MW; Honoré C; Lev DC; Colombo C; Bonvalot S; Mariani L; Pollock RE
    J Clin Oncol; 2013 May; 31(13):1649-55. PubMed ID: 23530096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.